Tradestie Institutional Equity Comparison Engine
MDT vs AXNX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MDT Overall Edge
MDT Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Medtronic plc (MDT) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, MDT trades at 16.5x Forward P/E with 20.1% operating margin (+13.7% YoY revenue) versus AXNX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MDT sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MDT
MDT 16.5x vs AXNX N/M Fwd P/E
Growth & Margin Winner
MDT
Op Margin 20.1% vs N/A ยท YoY +13.7% vs N/A
Momentum & Technical Winner
AXNX
1Y -0.4% vs +16.9% ยท 52W Pos 81% vs 50%
Options & Structure Winner
MDT
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (N/A IV)
MDT
NYSE
Medtronic plc
Electromedical & Electrotherapeutic Apparatus
$99.94
-0.67% 1D
Market Cap
$128.7B
1M Return
+3.47%
1Y Return
-0.4%
Forward P/E
16.5x
Unified AI Score
44.7 / 100
HOLD
Tech 31.0
Fund 49.0
Flow 72.0
Mom 46.0
AXNX
US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap
N/A
1M Return
-26.54%
1Y Return
+16.92%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MDT -0.4%
AXNX +16.92%
Spread: +9.47 pp (AXNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MDT TTM Op. Margin: 20.1%
AXNX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MDT vs AXNX. Trailing 12-month operating profitability (MDT 20.1% vs AXNX N/A) and valuation multiples (MDT 16.5x vs AXNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MDT | AXNX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $128.7B | N/A | Larger Scale | MDT |
| Trailing P/E Ratio Valuation | 24.7x | N/M | Lower Multiple | MDT |
| Forward P/E Ratio Valuation | 16.5x | N/M | Lower Multiple | MDT |
| Revenue Growth (YoY) Growth | +13.7% | N/A | Higher Growth | MDT |
| Operating Margin (TTM) Profitability | 20.1% | N/A | Higher Margin | MDT |
| Net Profit Margin Profitability | 13.9% | N/A | Higher Margin | MDT |
| Return on Equity (ROE) Capital Efficiency | 10.7% | N/A | Higher ROE | MDT |
| 52-Week Range Position Momentum | 81% ($73โ$106) | 50% ($0โ$1) | Stronger Trend | MDT |
| Beta / 30D Volatility Risk Regime | 0.13ฮฒ ยท 30% Vol | N/A | Lower Realized Risk | MDT |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 52.1 / 100 (HOLD) | Higher Composite | AXNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MDT vs AXNX Buy Guide
MDT
CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
AXNX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MDT nor AXNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.